High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry
Top Cited Papers
Open Access
- 21 May 2020
- journal article
- letter
- Published by Elsevier BV in Journal of Hepatology
- Vol. 73 (3), 705-708
- https://doi.org/10.1016/j.jhep.2020.05.013
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19The New England Journal of Medicine, 2020
- Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paperJHEP Reports, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Contemporary Epidemiology of Chronic Liver Disease and CirrhosisClinical Gastroenterology and Hepatology, 2019
- Influenza virus infection as precipitating event of acute-on-chronic liver failureJournal of Hepatology, 2019
- Decreasing Mortality Among Patients Hospitalized With Cirrhosis in the United States From 2002 Through 2010Gastroenterology, 2015
- Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevanceJournal of Hepatology, 2014